MedTrace Logo

Efficacy and Safety of a Treatment for Dry Eye Syndrome: Thealoz

NCT01742884 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-01-08

No results posted yet for this study

Summary

The purpose of this study is to determine if Thealoz is effective in Dry Eye Syndrome exposed to controlled adverse environmental conditions.

Conditions

  • Moderate Dry Eye Syndrome

Interventions

OTHER

Thealoz

Instillation of 1 drop of Thealoz

OTHER

Vehicle

1 drop of the vehicle will be instillated in the eye

Sponsors & Collaborators

  • Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA

    lead OTHER

Principal Investigators

  • Maria Jesus Gonzalez, PhD · IOBA - University of Valladolid

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01742884 on ClinicalTrials.gov